Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 13/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 13/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 11/20 | 0.40 |
| ▸ | TGFBR1 | P36897 | 2/20 | 0.35 |
| ▸ | ACVR1 | Q04771 | 2/20 | 0.35 |
| ▸ | HCRTR1 | O43613 | 2/20 | 0.34 |
| ▸ | HCRTR2 | O43614 | 2/20 | 0.34 |
| ▸ | FYN | P06241 | 1/20 | 0.34 |
| ▸ | ACVR1B | P36896 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13800733 | 0.92 | SLC6A2 (0.43) | SLC6A2SLC6A4SLC6A3TGFBR1ACVR1 | |
| Hydrochloric Acid SCHEMBL4120237 | 0.91 | SLC6A2 (0.43) | SLC6A2SLC6A4SLC6A3TGFBR1ACVR1 | |
| SCHEMBL13800574 | 0.91 | SLC6A2 (0.41) | SLC6A2SLC6A4SLC6A3TGFBR1ACVR1 | |
| SCHEMBL13800331 | 0.91 | SLC6A2 (0.45) | SLC6A2SLC6A4SLC6A3TGFBR1ACVR1 | |
| SCHEMBL13800349 | 0.90 | SLC6A2 (0.41) | SLC6A2SLC6A4SLC6A3TGFBR1ACVR1 | |
| SCHEMBL13800609 | 0.90 | SLC6A2 (0.39) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL13813538 | 0.90 | SLC6A2 (0.40) | SLC6A2SLC6A4SLC6A3TGFBR1ACVR1 | |
| Hydrochloric Acid SCHEMBL4109536 | 0.90 | SLC6A2 (0.40) | SLC6A2SLC6A4SLC6A3TGFBR1ACVR1 | |
| SCHEMBL13813507 | 0.90 | SLC6A2 (0.40) | SLC6A2SLC6A4SLC6A3TGFBR1ACVR1 | |
| Hydrochloric Acid SCHEMBL4127643 | 0.90 | SLC6A2 (0.44) | SLC6A2SLC6A4SLC6A3TGFBR1ACVR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090143430-A1 | ERYTHROPOIETIN PRODUCTION ACCELERATOR | KOWA CO., LTD. (JP) | 2009-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090143430-A1 | ERYTHROPOIETIN PRODUCTION ACCELERATOR | EPOR, GHRHR, ARL1 | SLC6A2 4192/4885SLC6A4 3416/4885SLC6A3 3947/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.